GLV Consulting OÜ

Active Registry code 11932066 OÜ Tallinn Registered 27 Apr 2010
Compare

GLV Consulting OÜ is a OÜ based in Tallinn, registry code 11932066, status: active. Main activity: Traditional, complementary and alternative medicine activities. Its annual report for 2025 shows revenue of €34 336 and 1 employees.

Turnover
—
State taxes
988 €
↑ 0.0% vs Q2 2026
Labour taxes
1 041 €
↑ 0.0% vs Q2 2026
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 34 336 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 3.0 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q4 2023 – Q3 2026
State taxes, € Q3 2026: 988 € · +0.0% vs Q2 2026
02004006008001 000Q4 2023 Company: 665 €Q4·23Q1 2024 Company: 723 €Q2 2024 Company: 752 €Q2·24Q3 2024 Company: 752 €Q4 2024 Company: 752 €Q4·24Q1 2025 Company: 858 €Q2 2025 Company: 911 €Q2·25Q3 2025 Company: 911 €Q4 2025 Company: 911 €Q4·25Q1 2026 Company: 962 €Q2 2026 Company: 988 €Q2·26Q3 2026 Company: 988 €Q3·2602004006008001 000Q4 2024 Company: 752 €Q1 2025 Company: 858 €Q1·25Q2 2025 Company: 911 €Q3 2025 Company: 911 €Q3·25Q4 2025 Company: 911 €Q1 2026 Company: 962 €Q1·26Q2 2026 Company: 988 €Q3 2026 Company: 988 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — 988 1 041 —
Q2 2026 — 988 1 041 —
Q1 2026 — 962 1 014 —
Q4 2025 — 911 960 —
Q3 2025 — 911 960 —
Q2 2025 — 911 960 —
Q1 2025 — 858 905 —
Q4 2024 — 752 795 —
Q3 2024 — 752 795 —
Q2 2024 — 752 795 —
Q1 2024 — 723 765 —
Q4 2023 — 665 705 —
Q3 2023 — 665 705 —
Q2 2023 — 947 1 005 —
Q1 2023 — 2 111 2 231 —
Q4 2022 — 2 218 2 339 1
Q3 2022 — 622 657 1
Q2 2022 — 622 657 —
Q1 2022 — 622 657 —

Financials by year

2016 – 2025
Revenue, € 2025: 34 336 € · +19.3% vs 2024 · industry median 20 811 € · above 58% of the industry
010 00020 00030 00040 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 39 769 € Industry median: 25 166 €20192020 Company: 23 731 € Industry median: 20 220 €20202021 Company: 26 464 € Industry median: 20 121 €20212022 Company: 30 835 € Industry median: 20 030 €20222023 Company: 29 592 € Industry median: 19 469 €20232024 Company: 28 778 € Industry median: 20 000 €20242025 Company: 34 336 € Industry median: 20 811 €2025010 00020 00030 00040 0002018 Company: — Industry median: —2019 Company: 39 769 € Industry median: 25 166 €20192020 Company: 23 731 € Industry median: 20 220 €2021 Company: 26 464 € Industry median: 20 121 €20212022 Company: 30 835 € Industry median: 20 030 €2023 Company: 29 592 € Industry median: 19 469 €20232024 Company: 28 778 € Industry median: 20 000 €2025 Company: 34 336 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 1 022 € · +43.3% vs 2024 · industry median 1 071 € · above 50% of the industry
01 0002 0003 0004 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 711 € Industry median: 2 596 €20192020 Company: 1 030 € Industry median: 2 208 €20202021 Company: 3 207 € Industry median: 1 834 €20212022 Company: 1 391 € Industry median: 1 525 €20222023 Company: 314 € Industry median: 1 745 €20232024 Company: 713 € Industry median: 1 621 €20242025 Company: 1 022 € Industry median: 1 071 €202501 0002 0003 0004 0002018 Company: — Industry median: —2019 Company: 711 € Industry median: 2 596 €20192020 Company: 1 030 € Industry median: 2 208 €2021 Company: 3 207 € Industry median: 1 834 €20212022 Company: 1 391 € Industry median: 1 525 €2023 Company: 314 € Industry median: 1 745 €20232024 Company: 713 € Industry median: 1 621 €2025 Company: 1 022 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 3.0 % · +0.5 pp vs the year before · industry median 8.3 % · above 37% of the industry
0510152016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 1.8 % Industry median: 10.3 %20192020 Company: 4.3 % Industry median: 12.4 %20202021 Company: 12.1 % Industry median: 13.0 %20212022 Company: 4.5 % Industry median: 11.3 %20222023 Company: 1.1 % Industry median: 11.4 %20232024 Company: 2.5 % Industry median: 10.7 %20242025 Company: 3.0 % Industry median: 8.3 %20250510152018 Company: — Industry median: —2019 Company: 1.8 % Industry median: 10.3 %20192020 Company: 4.3 % Industry median: 12.4 %2021 Company: 12.1 % Industry median: 13.0 %20212022 Company: 4.5 % Industry median: 11.3 %2023 Company: 1.1 % Industry median: 11.4 %20232024 Company: 2.5 % Industry median: 10.7 %2025 Company: 3.0 % Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 22 589 € · +5.4% vs 2024
05 00010 00015 00020 00025 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 16 139 €20192020 Company: 15 454 €20202021 Company: 18 646 €20212022 Company: 22 355 €20222023 Company: 21 234 €20232024 Company: 21 425 €20242025 Company: 22 589 €202505 00010 00015 00020 00025 0002018 Company: —2019 Company: 16 139 €20192020 Company: 15 454 €2021 Company: 18 646 €20212022 Company: 22 355 €2023 Company: 21 234 €20232024 Company: 21 425 €2025 Company: 22 589 €2025
Equity, € 2025: 21 091 € · +5.1% vs 2024
05 00010 00015 00020 00025 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 13 414 €20192020 Company: 14 444 €20202021 Company: 17 651 €20212022 Company: 19 042 €20222023 Company: 19 356 €20232024 Company: 20 069 €20242025 Company: 21 091 €202505 00010 00015 00020 00025 0002018 Company: —2019 Company: 13 414 €20192020 Company: 14 444 €2021 Company: 17 651 €20212022 Company: 19 042 €2023 Company: 19 356 €20232024 Company: 20 069 €2025 Company: 21 091 €2025
Employees 2025: 1 · +0.0% vs 2024 · industry median 2 · above 5% of the industry
01232016 Company: 2 Industry median: —20162017 Company: 1 Industry median: —20172018 Company: 2 Industry median: 320182019 Company: 2 Industry median: 320192020 Company: 3 Industry median: 320202021 Company: 1 Industry median: 2.520212022 Company: 2 Industry median: 220222023 Company: 1 Industry median: 220232024 Company: 1 Industry median: 220242025 Company: 1 Industry median: 2202501232018 Company: 2 Industry median: 32019 Company: 2 Industry median: 320192020 Company: 3 Industry median: 32021 Company: 1 Industry median: 2.520212022 Company: 2 Industry median: 22023 Company: 1 Industry median: 220232024 Company: 1 Industry median: 22025 Company: 1 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 34 336 1 022 13 175 22 589 21 091 1
2024 28 778 713 11 697 21 425 20 069 1
2023 29 592 314 13 431 21 234 19 356 1
2022 30 835 1 391 17 463 22 355 19 042 2
2021 26 464 3 207 9 321 18 646 17 651 1
2020 23 731 1 030 13 230 15 454 14 444 3
2019 39 769 711 18 396 16 139 13 414 2
2018 — — — — — 2
2017 — — — — — 1
2016 — — — — — 2
2015 — — — — — 2
2014 — — — — — 2
2013 — — — — — 2
2012 — — — — — 1
2011 — — — — — 1
2010 — — — — — 1

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
3.0 %
Net profit / revenue
Return on equity (ROE)
4.8 %
Net profit / equity
Return on assets (ROA)
4.5 %
Net profit / assets
Equity ratio
93.4 %
Equity / assets
Debt ratio
6.6 %
Liabilities / assets
Current ratio
12.52
Current assets / current liabilities
Revenue per employee
34 336 €
Revenue / average full-time employees
Labour cost per employee per month
1 098 €
Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 4 Jul 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 29 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 24 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 2 Jul 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 28 Nov 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 5 Oct 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 2 Feb 2021 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 86961Traditional, complementary and alternative medicine activities Main
  • 69202Bookkeeping, tax consulting
Rulings
Number, date Title Deadline State Document
Ä 10143232 / 11
10 Jul 2026
Amendment under Code of Civil Procedure § 595¹ (1) In force
10 Jul 2026
PDF
Ä 10143232 / 10
2 Sep 2023
Amendment entry In force
2 Sep 2023
PDF
Ä 10143232 / M3
3 Feb 2023
Ruling to correct data outside an entry Deficiencies eliminated
6 Feb 2023
PDF
Ä 10143232 / 9
5 Oct 2021
Amendment entry In force
5 Oct 2021
PDF
Ä 10143232 / 8
18 Jun 2018
Amendment under Commercial Code § 525 (2) In force
18 Jun 2018
PDF
Ä 10143232 / 7
6 Apr 2018
Amendment entry In force
6 Apr 2018
PDF
Ä 10143232 / M2
21 Mar 2018
Warning of deletion from the register: annual report not filed 21 Sep 2018 Deficiencies eliminated
6 Apr 2018
PDF
Ä 10143232 / 6
17 Jan 2018
Amendment entry In force
17 Jan 2018
PDF
Ä 10143232 / 5
1 Dec 2017
Amendment entry In force
1 Dec 2017
PDF
Ä 10143232 / 4
19 Oct 2016
Amendment entry In force
19 Oct 2016
PDF
Ä 10143232 / 3
16 Sep 2016
Amendment entry In force
16 Sep 2016
PDF
Ä 10143232 / 2
19 Oct 2011
Amendment entry In force
19 Oct 2011
PDF
Ä 10143232 / M1
6 Oct 2011
Ruling to eliminate deficiencies 7 Nov 2011 In force
6 Oct 2011
PDF
Ä 10143232
27 Apr 2010
First entry In force
27 Apr 2010
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data